Caption Health’s AI-guide ultrasound technology
The company’s FDA cleared system uses AI to assist healthcare providers, providing guidance as ultrasounds are being taken, allowing lesser trained clinicians to capture high quality images, as well as using algorithms trained on thousands of existing patients to assist in interpretation.
Since its foundation in 2013, the company has raised some across five funding rounds. Its latest , announced earlier this week, saw the company raise $53mn from lead investor DCVC, alongside Atlantic Bridge, Edwards Lifesciences and Khosla Ventures.
In , Charles Cadieu, CEO of Caption Health, said:"We are truly grateful to our investors and to our early adopter clinicians, who have believed in us from the beginning. This capital will enable us to scale our collaborations with leading research institutions, regional health systems and other providers by making ultrasound available where and when it is needed—across departments, inside and outside the hospital. As the world's first and only AI-guided ultrasound technology, our goal is to enable all clinicians -- regardless of prior experience—to capture diagnostic-quality ultrasounds. In doing so, we aim to have a profound impact on the quality and cost of care for millions of patients around the globe—wherever they access care."
Caption Health said it would use the funding to further develop its AI platform, as well as forming new partnerships and scaling up its operations.
"Caption Health is working towards a future where looking inside the body becomes as routine as a blood pressure cuff measurement. Simplifying ultrasound is critical to providing fast, effective care," said Armen Vidian, Partner at DCVC. "By making ultrasound accessible to non-specialists with AI-guided, FDA-cleared products, Caption AI brings the benefits of medical imaging to more caregivers in more settings."